19 Alzheimers Disease Clinical Trials in Austin, MN (2026)

Q: How do I join a clinical trial in Austin?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you.

Recruiting Alzheimers Disease Studies in Austin

NCT05458219Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic s...

Austin, MN470 participantsInnovent Biologics (Suzhou) Co. Ltd.

View Study Details

NCT05320588Recruiting

A Study in Patients With Advanced Cancers

A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers....

Austin, MN332 participantsBiOneCure Therapeutics Inc.

View Study Details

NCT06818643Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumor...

Austin, MN270 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06657222Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030. The main questions it aims to answer are: To ...

Austin, MN250 participantsTubulis GmbH

View Study Details

NCT07109726Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of TER-2013 in patients with advanced solid tumors ha...

Austin, MN205 participantsTerremoto Biosciences Inc.

View Study Details

NCT07227168Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

This is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer. This study includes 3 parts: * Part 1A is a dose escalation study of STRO-004 ...

Austin, MN200 participantsSutro Biopharma, Inc.

View Study Details

NCT06444841Recruiting

Paper-Based and Smartphone-Based Memory Supports

Alzheimer's disease and related dementias lead to marked declines in daily functioning, independence, and quality of life. One of the earliest cognitive changes in these conditions is impairment in pr...

Austin, MN200 participantsBaylor University

View Study Details

NCT03082755Recruiting

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking...

Austin, MN156 participantsUniversity of Texas at Austin

View Study Details

NCT07612189Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

This is a first in human (FIH), Phase 1 dose escalation and expansion study in select solid tumors. This study includes 2 parts: a Dose Escalation and Backfill portion (Part A) and a Dose Expansion po...

Austin, MN155 participantsNEOK Bio, Inc.

View Study Details

NCT07488676Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the ...

Austin, MN150 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT06270706Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

This is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity of PLN-101095 in com...

Austin, MN124 participantsPliant Therapeutics, Inc.

View Study Details

NCT06511752Recruiting

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The curr...

Austin, MN120 participantsUniversity of Texas at Austin

View Study Details

NCT07361562Recruiting

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

This is an open-label, phase 1/1b study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), pharmacodynamic (what the drug does to the body), and antitumor activity ...

Austin, MN100 participantsCogent Biosciences, Inc.

View Study Details

NCT05798897Recruiting

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starti...

Austin, MN79 participantsMarker Therapeutics, Inc.

View Study Details

NCT07370311Recruiting

A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions

Family caregivers of people with dementia have to decide between tube feeding and hand feeding when persistent eating problems arise. This decision can be difficult for Chinese American dementia careg...

Austin, MN60 participantsYaolin Pei

View Study Details

NCT04617522Recruiting

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

The goals of this clinical study are to learn more about the safety and dosing of the study drug, sacituzumab govitecan-hziy, in participants with solid tumors and moderate liver problems....

Austin, MN30 participantsGilead Sciences

View Study Details

NCT07285629Recruiting

Safety and Efficacy of Klotho and Follistatin Gene Therapy

The purpose of this study is to investigate the safety and efficacy of a combination klotho and follistatin gene therapy, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, th...

Austin, MN30 participantsMinicircle

View Study Details

NCT07216781Recruiting

Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans

The purpose of this study is to investigate the safety and efficacy of a gene therapy for Klotho, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to unders...

Austin, MN24 participantsMinicircle

View Study Details

NCT07547683Recruiting

Usability of the Regen Gait Therapy Robot in Healthy Adults

Regen is a robot-assisted device designed to help therapists and improve the quality of treatment. It works by replicating the movement of the therapist and providing assistance as needed for the pati...

Austin, MN10 participantsUniversity of Texas at Austin

View Study Details

About Alzheimers Disease Clinical Trials in Austin

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 19 alzheimers disease clinical trials recruiting participants in Austin, MN. These studies are seeking a combined 2,965 participants. Research is being sponsored by Innovent Biologics (Suzhou) Co. Ltd., BiOneCure Therapeutics Inc., Merck Sharp & Dohme LLC and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Austin — FAQ

Are there alzheimers disease clinical trials in Austin?

Yes, there are 19 alzheimers disease clinical trials currently recruiting in Austin, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 19 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 13, 2026 from ClinicalTrials.gov